Title:
NOVEL PHENYLAMINOPYRIMIDINE COMPOUND HAVING INHIBITORY ACTIVITY AGAINST LRRK2 AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2022/203466
Kind Code:
A1
Abstract:
The present invention provides a pyrimidine compound of chemical formula 1, a pharmaceutical composition containing same for preventing or treating a LRRK2-mediated or related disease (for example, Parkinson's disease), and a method for treating and preventing disorders or diseases by using same. Having inhibitory activity against LRRK2, the pyrimidine compound according to the present invention can be advantageously used for preventing or treating LRRK2-related diseases (for example, Parkinson's disease).
Inventors:
KANG EUNJI (KR)
SHIN JAE HONG (KR)
KIM HYUN JIN (KR)
LEE JAEYOUNG (KR)
CHO DAE HYUN (KR)
KO EUN (KR)
KIM SEUNG CHAN (KR)
SONG SANG OK (KR)
SHIN JAE HONG (KR)
KIM HYUN JIN (KR)
LEE JAEYOUNG (KR)
CHO DAE HYUN (KR)
KO EUN (KR)
KIM SEUNG CHAN (KR)
SONG SANG OK (KR)
Application Number:
PCT/KR2022/004259
Publication Date:
September 29, 2022
Filing Date:
March 25, 2022
Export Citation:
Assignee:
STANDIGM INC (KR)
International Classes:
C07D403/14; A61K31/505; A61K31/506; A61K31/55; A61P25/16; A61P25/28; C07D239/42; C07D401/12; C07D403/04; C07D403/12
Foreign References:
| CN111732548A | 2020-10-02 | |||
| KR20200110250A | 2020-09-23 | |||
| US20130029944A1 | 2013-01-31 | |||
| US20070259904A1 | 2007-11-08 | |||
| KR20180097162A | 2018-08-30 |
Attorney, Agent or Firm:
RYU, Jong Woo et al. (KR)
Download PDF: